4//SEC Filing
Andrews William T. 4
Accession 0001209191-20-054614
CIK 0001662524other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 3:56 PM ET
Size
7.2 KB
Accession
0001209191-20-054614
Insider Transaction Report
Form 4
Andrews William T.
Chief Medical Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2020-10-12$4.86/sh−250,000$1,215,000→ 0 totalExercise: $13.29Exp: 2030-07-08→ Common Stock (250,000 underlying) - Disposition from Tender
Common Stock
2020-10-12$18.15/sh−37,500$680,625→ 0 total
Footnotes (1)
- [F1]This option, which provided that 1/4th of the shares would vest one year after July 9, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $1,215,000.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
Documents
Issuer
AKCEA THERAPEUTICS, INC.
CIK 0001662524
Entity typeother
Related Parties
1- filerCIK 0001638459
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 3:56 PM ET
- Size
- 7.2 KB